Author:
Janicki Joseph S.,Shroff Sanjeev G.,Weber Karl T.
Subject
Cardiology and Cardiovascular Medicine
Reference27 articles.
1. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1,3 Dihydro-4methyl-5 [4-(methyithio)-benzoyl]-2H-imidazol-2-one);Dage;J Cardiovasc Pharmacol,1982
2. Biochemical studies on the mechanism of cardiotonic activity of MDL 17,043. Possible involvement of cyclic AMP phosphodiesterase inhibition;Kariya;J Cardiovasc Pharmacol,1982
3. Characterization of the cardiovascular activities of a new cardiotonic agent, MDL 17,043 (1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazole-2-one);Roebel;J Cardiovasc Pharmacol,1982
4. Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance;Crawford;Am J Cardiol,1984
5. Effects of a new cardiotonic agent, MDL-17,043, on myocardial contractility and left ventricular performance in congestive heart failure;Strain;Am Heart J,1985
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献